title: Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
authors.affiliation: Department of Internal Medicine, Stanford Hospital and Clinics, Stanford, CA.
authors.forename: Nathaniel J
authors.initials: NJ
authors.lastname: Myall
authors.affiliation: Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA.
authors.forename: Joel W
authors.initials: JW
authors.lastname: Neal
authors.affiliation: Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA.
authors.forename: Cheryl D
authors.initials: CD
authors.lastname: Cho-Phan
authors.affiliation: Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA.
authors.forename: Lisa Y
authors.initials: LY
authors.lastname: Zhou
authors.affiliation: Department of Radiation Oncology, Stanford Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.
authors.forename: Henning
authors.initials: H
authors.lastname: Stehr
authors.affiliation: Department of Radiation Oncology, Stanford Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.
authors.forename: Li
authors.initials: L
authors.lastname: Zhou
authors.affiliation: Department of Radiation Oncology, Stanford Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Diehn
authors.affiliation: Division of Medical Oncology, Stanford Hospital and Clinics, Stanford, CA. Electronic address: hwakelee@stanford.edu.
authors.forename: Heather A
authors.initials: HA
authors.lastname: Wakelee
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics*; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics*; D018450:Disease Progression; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D058990:Molecular Targeted Therapy; D009154:Mutation / Q000235:genetics*; D057285:Precision Medicine; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics*; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D000069347:Erlotinib Hydrochloride; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf
keywords: Adenocarcinoma; Cancer personalized profiling; Targeted therapy; Vemurafenib